LIFECORE BIOMEDICAL, INC. Insurance Recoveries
LIFECORE BIOMEDICAL, INC. (LFCR) reported Insurance Recoveries of $1.60 million for the 3-month period ending 2021-05-30, per its 10-Q filed 2023-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InsuranceRecoveries · last filed 2024-03-20
- LIFECORE BIOMEDICAL, INC. insurance recoveries for the quarter ending 2021-05-30 was $1.60M.
- LIFECORE BIOMEDICAL, INC. insurance recoveries for the quarter ending 2021-02-28 was $1.60M.
| Period end | Insurance Recoveries 3 month | Insurance Recoveries 6 month | Insurance Recoveries 9 month |
|---|---|---|---|
| 2021-05-30 | $1.60M 10-Q · filed 2023-03-16 | $3.20M derived: sum of 2 quarters · filed 2024-03-20 | |
| 2021-02-28 | $1.60M 10-K · filed 2024-03-20 | $1.60M 10-Q · filed 2021-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |